Prof Michal Alberstein, PI of the European Research Council-funded project ‘Judicial Conflict Resolution’, discusses her view on the future of the judicial role.
Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
The Nuclear Theory Group at the University of York, United Kingdom, develops novel theoretical methods for a precise description of ground and exited nuclear states, more of which is explained here by Jacek Dobaczewski, Chair in Theoretical Nuclear Physics.
Dr Alfred Msezane from the Department of Physics, Clark Atlanta University, explains ground state negative ion formation in complex heavy systems, including comment on electron affinity determination.
Associate Professor Marco Beleggia from the Technical University of Denmark, explains to us how to refocus spin structures with Lorentz transmission electron microscopy.
Peter H. Santschi, Professor at Texas A&M University at Galveston, TX, shares his expert thoughts on the mobility of iodine species in the environment and solid waste.
Richard Beardsworth, Professor and Head of School, School of Politics and International Studies, University of Leeds, provides the second article of a series on progressive state leadership.
Romola Davenport and Richard Smith, Cambridge Group for the History of Population and Social Structure, Department of Geography, University of Cambridge, explore the history and evolution of public health, in this article.
Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.
Suzi Daley, External Affairs Manager at United Kingdom Accreditation Service (UKAS), focuses her thoughts on customer rating review systems online and UKAS accreditation in the health and social care system.
Here, UKCloud explains how businesses can take advantage of Data Centre Modernisation, whilst still focusing on their core business and avoiding key pitfalls of digital transformation.
Contributing scientists share their thoughts around the field of chemistry, focussing on enzyme activity assays for disease diagnosis, novel drug development validation and nanoparticles.
